Evolving therapies to greatly aid in controlling obesity

Treatment for obesity traditionally involves diet therapy and lifestyle modifications such as physical exercise. However, conventional therapies alone are not always sufficient in achieving desired weight loss, as they have their own limitations.  The decreased food intake may lead to nutritional deficiencies and the obese may find it difficult to strictly follow the diet regimen. Hence these difficulties in long-term weight management are encouraging patients to look for more effective treatment options with guaranteed results.

Emerging anti-obesity treatment therapies such as pharmacotherapy, bariatric surgeries, as well as the use of weight loss devices will help meet the rising need to reduce the prevalence of obesity and its associated health risks.

If you are interested in a virtual brochure, which provides manufacturers, end users, and other industry participants with an overview of the latest analysis on Clinical Management of Obesity, then send an e-mail to Shwetha Thomas/ Samantha Unnikrishnan, Corporate Communications, at sthomas@frost.com / sunnikrishnan@frost.com with your full name, company name, title, telephone number, e-mail address, city, state, and country. We will send you the overview by e-mail upon receipt of the above information.

“Pharmacotherapy, is an Food and Drug Administration (FDA) approved treatment for patients who have not responded to diet therapy and physical exercises,” states Frost & Sullivan Research Analyst Sangeetha Prabakar. “It is recommended, both, for obese individuals with a body mass index (BMI) of 30+ who do not have any associated health risks such as type 2 diabetes, heart disease, hypertension, and stroke in addition to moderately obese patients with two or more collateral conditions.”

Contd on page 2....